NASALCARE - Trademark Details
Status: 800 - Registered And Renewed
Serial Number
77504998
Registration Number
3688173
Word Mark
NASALCARE
Status
800 - Registered And Renewed
Status Date
2020-01-07
Filing Date
2008-06-22
Registration Number
3688173
Registration Date
2009-09-29
Mark Drawing
3000 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s)
Typeset
Design Searches
011505, 261702 - Smoke, steam and vapor. Wavy line(s), band(s) or bar(s).
Published for Opposition Date
2009-01-20
Law Office Assigned Location Code
M10
Employee Name
BENJAMIN, SARA NICOLE
Statements
Indication of Colors claimed
Color is not claimed as a feature of the mark.
Disclaimer with Predetermined Text
"NASALCARE"
Description of Mark
The mark consists of the wording "NASALCARE" with two curved lines representing air or vapor emanating from the "L".
Goods and Services
[ Analgesic and muscle relaxant pharmaceutical preparations; Anti-diabetic pharmaceuticals; ] Antibacterial pharmaceuticals; [ Antimicrobial preparations for inhibiting microbiological decomposition in food, beverages, animal feed and pharmaceuticals; ] [ Antimicrobial preservatives for cosmetics and pharmaceuticals; ] [ Astringents; Bismuth preparations for pharmaceutical purposes; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; ] Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; [ Drug delivery agents in the form of a coating for macromolecule agents that facilitate the delivery of a wide range of pharmaceuticals; Gelatin capsules sold empty for pharmaceuticals; ] Homeopathic pharmaceuticals for use in the treatment of allergy and respiratory tract infections; [ Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Inhalers filled with anti-infectives and anti-allergy pharmaceuticals; ] [ Injectable pharmaceuticals for treatment of anaphylactic reactions; Intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; Ocular pharmaceuticals; Pharmaceutical anti-allergic preparations and substances; ] Pharmaceutical antitussive-cold preparations; [ Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; ] Pharmaceutical preparations and substances for the treatment of infectious diseases, [ blood disorders, ] pain, inflammation [, sepsis, alopecia, obesity and cognitive disorders ] ; [ Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; ] Pharmaceutical preparations for the prevention and treatment of [ ocular disorders or diseases, for the treatment of ] bacteria-based diseases, [ and for the treatment of diabetes, ] and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations [ and vaccines ] ; [ Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; ] Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for treating allergic rhinitis and asthma; [ Pharmaceutical preparations for treating diabetes; ] Pharmaceutical preparations for use in chemotherapy; [ Pharmaceutical preparations for use in urology; Pharmaceutical preparations for wounds; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical preparations, namely, appetite suppressants; Pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparations, namely, anticoagulants; Pharmaceutical products and preparations against dry skin caused by pregnancy; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for the treatment of joint disease; ] Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; [ Pharmaceutical solutions used in dialysis; Pharmaceuticals for the treatment of erectile dysfunction; ] Pharmaceuticals, namely, anti-infectives; [ Pharmaceuticals, namely, antihelmintics; ] [ Pharmaceuticals, namely, inducers of erections; Pharmaceuticals, namely, lipid lowering agents; Plant extracts for medical, veterinary and pharmaceutical purposes; ] [ Potassium preparations for pharmaceutical purposes; ] [ Radioactive pharmaceutical preparations for use in vivo diagnostic or therapeutic use; Synthetic peptides for pharmaceutical purposes; Unit dose capsules sold empty for pharmaceutical use; Vitamin and mineral preparations for use as ingredients in the food and pharmaceutical industry; Yeast or yeast extracts for medical, veterinary or pharmaceutical purposes ]
Pseudo Mark
NASAL CARE
Pseudo Mark
NASAL CARE
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2008-06-25
Primary Code
005
First Use Anywhere Date
2007-01-02
First Use In Commerce Date
2007-01-02
Current Trademark Owners
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Lilly Zhang
Address
Please log in with your Justia account to see this address.
Trademark Events
Event Date | Event Description |
2008-06-25 | NEW APPLICATION ENTERED IN TRAM |
2008-06-26 | NOTICE OF DESIGN SEARCH CODE MAILED |
2008-09-26 | ASSIGNED TO EXAMINER |
2008-10-03 | NON-FINAL ACTION WRITTEN |
2008-10-03 | NON-FINAL ACTION E-MAILED |
2008-10-03 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2008-12-01 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2008-12-01 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
2008-12-16 | ASSIGNED TO LIE |
2008-12-16 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2008-12-16 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2008-12-16 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2008-12-16 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
2008-12-31 | NOTICE OF PUBLICATION |
2009-01-20 | PUBLISHED FOR OPPOSITION |
2009-02-04 | EXTENSION OF TIME TO OPPOSE RECEIVED |
2009-03-12 | OPPOSITION INSTITUTED NO. 999999 |
2009-08-26 | OPPOSITION DISMISSED NO. 999999 |
2009-08-26 | OPPOSITION TERMINATED NO. 999999 |
2009-08-26 | TTAB RELEASE CASE TO TRADEMARKS |
2009-09-29 | REGISTERED-PRINCIPAL REGISTER |
2014-09-30 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
2014-09-30 | TEAS SECTION 8 & 15 RECEIVED |
2014-10-06 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
2014-10-06 | POST REGISTRATION ACTION MAILED - SEC. 8 & 15 |
2014-11-24 | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED |
2014-12-13 | POST REGISTRATION ACTION MAILED - SEC. 8 & 15 |
2016-03-25 | TEAS SECTION 8 & 15 RECEIVED |
2016-03-25 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
2016-03-28 | POST REGISTRATION ACTION MAILED - SEC. 8 & 15 |
2016-04-03 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
2016-04-08 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
2016-05-27 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
2016-06-06 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
2016-09-27 | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED |
2016-09-28 | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED |
2016-10-12 | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
2016-10-12 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED |
2018-09-29 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED |
2019-06-21 | TEAS SECTION 8 & 9 RECEIVED |
2019-06-21 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
2019-07-07 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
2019-07-07 | POST REGISTRATION ACTION MAILED - SEC. 8 & 9 |
2020-01-03 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
2020-01-06 | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED |
2020-01-07 | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED |
2020-01-07 | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) |
2020-01-07 | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED |